Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/AURORA_trial> ?p ?o }
Showing triples 1 to 32 of
32
with 100 triples per page.
- AURORA_trial abstract "The AURORA trial (A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiovascular Events) was a randomized, double-blind, placebo-controlled study investigating the use of rosuvastatin in the prevention of cardiovascular disease among patients undergoing chronic hemodialysis.The trial was undertaken because although patients with end-stage renal disease (ESRD) are at high risk of adverse cardiovascular events, no large clinical trial had confirmed the benefit of lipid-lowering agents. The AURORA trial sought to fill this gap.The trial was conducted across 280 medical centers in 25 countries. The study randomized 2776 patients, aged 50–80 years and undergoing maintenance hemodialysis, to one of two groups. One group received rosuvastatin 10 mg daily and the other group received a placebo. The combined primary end point was death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke. Although the mean LDL cholesterol was reduced by 43% in the rosuvastatin arm of the study at three months, no difference in the primary end point was demonstrated at an average follow-up of 3.8 years.The trial was sponsored, in part, by AstraZeneca, the marketer of Crestor.".
- AURORA_trial wikiPageExternalLink NCT00240331.
- AURORA_trial wikiPageID "22230433".
- AURORA_trial wikiPageLength "2426".
- AURORA_trial wikiPageOutDegree "15".
- AURORA_trial wikiPageRevisionID "704548457".
- AURORA_trial wikiPageWikiLink AstraZeneca.
- AURORA_trial wikiPageWikiLink Blind_experiment.
- AURORA_trial wikiPageWikiLink Cardiovascular_disease.
- AURORA_trial wikiPageWikiLink Category:Clinical_trials_sponsored_by_AstraZeneca.
- AURORA_trial wikiPageWikiLink Hemodialysis.
- AURORA_trial wikiPageWikiLink Lipid-lowering_agent.
- AURORA_trial wikiPageWikiLink Low-density_lipoprotein.
- AURORA_trial wikiPageWikiLink Myocardial_infarction.
- AURORA_trial wikiPageWikiLink Placebo.
- AURORA_trial wikiPageWikiLink Placebo-controlled_study.
- AURORA_trial wikiPageWikiLink Randomized_controlled_trial.
- AURORA_trial wikiPageWikiLink Rosuvastatin.
- AURORA_trial wikiPageWikiLink Stroke.
- AURORA_trial wikiPageWikiLinkText "AURORA trial".
- AURORA_trial wikiPageUsesTemplate Template:Reflist.
- AURORA_trial subject Category:Clinical_trials_sponsored_by_AstraZeneca.
- AURORA_trial hypernym Study.
- AURORA_trial type Book.
- AURORA_trial type Trial.
- AURORA_trial comment "The AURORA trial (A Study to Evaluate the Use of Rosuvastatin in Subjects on Regular Hemodialysis: An Assessment of Survival and Cardiovascular Events) was a randomized, double-blind, placebo-controlled study investigating the use of rosuvastatin in the prevention of cardiovascular disease among patients undergoing chronic hemodialysis.The trial was undertaken because although patients with end-stage renal disease (ESRD) are at high risk of adverse cardiovascular events, no large clinical trial had confirmed the benefit of lipid-lowering agents. ".
- AURORA_trial label "AURORA trial".
- AURORA_trial sameAs Q4654994.
- AURORA_trial sameAs m.05q6zs9.
- AURORA_trial sameAs Q4654994.
- AURORA_trial wasDerivedFrom AURORA_trial?oldid=704548457.
- AURORA_trial isPrimaryTopicOf AURORA_trial.